Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies - PubMed (original) (raw)

Review

. 2009 Dec 25;625(1-3):220-33.

doi: 10.1016/j.ejphar.2009.06.063. Epub 2009 Oct 15.

Affiliations

• PMID: 19836374
• DOI: 10.1016/j.ejphar.2009.06.063

Review

Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies

V Raja Solomon et al. Eur J Pharmacol. 2009.

Abstract

Chloroquine (CQ), N'-(7-chloroquinolin-4-yl)-N,N-diethyl-pentane-1,4-diamine, is widely used as an effective and safe anti-malarial and anti-rheumatoid agent. CQ was discovered 1934 as "Resochin" by Andersag and co-workers at the Bayer laboratories. Ironically, CQ was initially ignored for a decade because it was considered too toxic to use in humans. CQ was "re-discovered" during World War II in the United States in the course of anti-malarial drug development. The US government-sponsored clinical trials during this period showed unequivocally that CQ has a significant therapeutic value as an anti-malarial drug. Consequently, CQ was introduced into clinical practice in 1947 for the prophylaxis treatment of malaria (Plasmodium vivax, ovale and malariae). CQ still remains the drug of choice for malaria chemotherapy because it is highly effective and well tolerated by humans. In addition, CQ is widely used as an anti-inflammatory agent for the treatment of rheumatoid arthritis, lupus erythematosus and amoebic hepatitis. More recently, CQ has been studied for its potential as an enhancing agent in cancer therapies. Accumulating lines of evidence now suggest that CQ can effectively sensitize cell-killing effects by ionizing radiation and chemotherapeutic agents in a cancer-specific manner. The lysosomotrophic property of CQ appears to be important for the increase in efficacy and specificity. Although more studies are needed, CQ may be one of the most effective and safe sensitizers for cancer therapies. Taken together, it appears that the efficacy of conventional cancer therapies can be dramatically enhanced if used in combination with CQ and its analogs.

PubMed Disclaimer

Similar articles

• The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine.
  Hu C, Solomon VR, Ulibarri G, Lee H. Hu C, et al. Bioorg Med Chem. 2008 Sep 1;16(17):7888-93. doi: 10.1016/j.bmc.2008.07.076. Epub 2008 Jul 29. Bioorg Med Chem. 2008. PMID: 18691894
• The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
  Fukuda T, Oda K, Wada-Hiraike O, Sone K, Inaba K, Ikeda Y, Miyasaka A, Kashiyama T, Tanikawa M, Arimoto T, Kuramoto H, Yano T, Kawana K, Osuga Y, Fujii T. Fukuda T, et al. Gynecol Oncol. 2015 Jun;137(3):538-45. doi: 10.1016/j.ygyno.2015.03.053. Epub 2015 Apr 1. Gynecol Oncol. 2015. PMID: 25842161
• Design and synthesis of chloroquine analogs with anti-breast cancer property.
  Solomon VR, Hu C, Lee H. Solomon VR, et al. Eur J Med Chem. 2010 Sep;45(9):3916-23. doi: 10.1016/j.ejmech.2010.05.046. Epub 2010 May 31. Eur J Med Chem. 2010. PMID: 20561720
• [Development of antituberculous drugs: current status and future prospects].
  Tomioka H, Namba K. Tomioka H, et al. Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
• Autophagy inhibition in combination cancer treatment.
  Livesey KM, Tang D, Zeh HJ, Lotze MT. Livesey KM, et al. Curr Opin Investig Drugs. 2009 Dec;10(12):1269-79. Curr Opin Investig Drugs. 2009. PMID: 19943199 Review.

Cited by

• Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.
  Ghadimi MP, Lopez G, Torres KE, Belousov R, Young ED, Liu J, Brewer KJ, Hoffman A, Lusby K, Lazar AJ, Pollock RE, Lev D. Ghadimi MP, et al. Mol Cancer Ther. 2012 Aug;11(8):1758-69. doi: 10.1158/1535-7163.MCT-12-0015. Epub 2012 Jul 30. Mol Cancer Ther. 2012. PMID: 22848094 Free PMC article.
• The past, present and future of RNA respiratory viruses: influenza and coronaviruses.
  Makarov V, Riabova O, Ekins S, Pluzhnikov N, Chepur S. Makarov V, et al. Pathog Dis. 2020 Oct 7;78(7):ftaa046. doi: 10.1093/femspd/ftaa046. Pathog Dis. 2020. PMID: 32860686 Free PMC article. Review.
• Oxidized Phospholipids in Tumor Microenvironment Stimulate Tumor Metastasis via Regulation of Autophagy.
  Seok JK, Hong EH, Yang G, Lee HE, Kim SE, Liu KH, Kang HC, Cho YY, Lee HS, Lee JY. Seok JK, et al. Cells. 2021 Mar 4;10(3):558. doi: 10.3390/cells10030558. Cells. 2021. PMID: 33806593 Free PMC article.
• Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.
  Harhaji-Trajkovic L, Arsikin K, Kravic-Stevovic T, Petricevic S, Tovilovic G, Pantovic A, Zogovic N, Ristic B, Janjetovic K, Bumbasirevic V, Trajkovic V. Harhaji-Trajkovic L, et al. Pharm Res. 2012 Aug;29(8):2249-63. doi: 10.1007/s11095-012-0753-1. Epub 2012 Apr 27. Pharm Res. 2012. PMID: 22538436
• PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
  Roy A, Chakraborty AR, DePamphilis ML. Roy A, et al. Mol Oncol. 2024 Apr;18(4):988-1011. doi: 10.1002/1878-0261.13607. Epub 2024 Feb 27. Mol Oncol. 2024. PMID: 38414326 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database